0,687  0,004  Muscle relaxant
0,673  0,005  CYP2D6 inhibitor
0,669  0,012  Prostate cancer treatment
0,669  0,022  Antineoplastic (lung cancer)
0,637  0,011  5 Hydroxytryptamine release stimulant
0,625  0,004  Skeletal muscle relaxant
0,600  0,004  Alpha 2 adrenoreceptor antagonist
0,621  0,045  Apoptosis agonist
0,595  0,024  Antineoplastic (colorectal cancer)
0,593  0,023  Antineoplastic (colon cancer)
0,572  0,004  Antiparkinsonian, rigidity relieving
0,579  0,017  Antineoplastic (ovarian cancer)
0,548  0,009  Antimitotic
0,569  0,040  Antineoplastic (breast cancer)
0,544  0,023  Respiratory analeptic
0,534  0,017  CYP2C19 inhibitor
0,489  0,008  Tubulin antagonist
0,506  0,031  Immunosuppressant
0,496  0,022  Antineoplastic (pancreatic cancer)
0,514  0,048  Antineoplastic (solid tumors)
0,513  0,055  Caspase 9 stimulant
0,455  0,004  Alpha 2a adrenoreceptor antagonist
0,452  0,007  Alpha adrenoreceptor antagonist
0,436  0,009  Antineoplastic (squamous cell carcinoma)
0,446  0,019  Antineoplastic (lymphoma)
0,440  0,016  Sigma receptor agonist
0,402  0,005  Alpha 2b adrenoreceptor antagonist
0,401  0,010  Topoisomerase II inhibitor
0,414  0,025  Antineoplastic (glioblastoma multiforme)
0,384  0,005  5 Hydroxytryptamine 7 antagonist
0,413  0,037  CYP1A2 substrate
0,394  0,021  Antineoplastic enhancer
0,409  0,042  Caspase 3 stimulant
0,409  0,044  Antidepressant
0,391  0,045  CYP2D6 substrate
0,383  0,039  Antineoplastic (glioma)
0,379  0,038  CYP3A4 inhibitor
0,401  0,062  CYP3A4 substrate
0,342  0,013  5 Hydroxytryptamine 2 antagonist
0,383  0,056  Mood disorders treatment
0,334  0,011  Erectile dysfunction treatment
0,368  0,046  Analeptic
0,351  0,034  Antineoplastic (small cell lung cancer)
0,336  0,019  Male reproductive disfunction treatment
0,377  0,071  CYP2C9 substrate
0,324  0,019  Antineoplastic (carcinoma)
0,343  0,039  Cardiodepressant
0,343  0,040  Tumour necrosis factor alpha release inhibitor
0,358  0,057  Hepatic disorders treatment
0,354  0,052  Antineoplastic (melanoma)
0,351  0,052  Spasmolytic
0,314  0,017  5 Hydroxytryptamine antagonist
0,340  0,044  DNA damaging
0,305  0,010  Topoisomerase I inhibitor
0,309  0,016  Liver fibrosis treatment
0,296  0,006  Dopamine D1 antagonist
0,335  0,049  Antineoplastic (cervical cancer)
0,287  0,005  Dopamine agonist
0,298  0,019  Neurotrophic factor enhancer
0,351  0,076  Transcription factor NF kappa B inhibitor
0,332  0,059  Antineoplastic (brain cancer)
0,269  0,010  5 Hydroxytryptamine 1A antagonist
0,260  0,004  Antineoplastic alkaloid
0,334  0,079  Antineoplastic (non-Hodgkin's lymphoma)
0,391  0,144  Antiinflammatory
0,273  0,037  Hepatoprotectant
0,284  0,049  DNA synthesis inhibitor
0,239  0,005  Dopamine D2 agonist
0,319  0,094  Antileukemic
0,233  0,016  5 Hydroxytryptamine 2A antagonist
0,257  0,045  Abortion inducer
0,230  0,019  Antiadrenergic
0,224  0,015  5 Hydroxytryptamine 1 antagonist
0,225  0,024  Carcinogenic, group 1
0,219  0,020  Adrenaline antagonist
0,212  0,017  Dopamine antagonist
0,255  0,064  Tyrosine 3 hydroxylase inhibitor
0,263  0,072  Antineoplastic (non-small cell lung cancer)
0,206  0,017  Alpha 2c adrenoreceptor antagonist
0,235  0,047  P-glycoprotein inhibitor
0,248  0,070  Vasodilator
0,202  0,025  DNA intercalator
0,206  0,029  Acetylcholine antagonist
0,239  0,063  Psychostimulant
0,202  0,027  Antiviral (Hepatitis B)
0,205  0,031  Cholinergic antagonist
0,187  0,017  Topoisomerase II alpha inhibitor
0,175  0,005  Dopamine D5 antagonist
0,179  0,010  CDC-like kinase 3 inhibitor
0,202  0,034  Genotoxic
0,203  0,042  Antiischemic, cerebral
0,255  0,096  Hypoxia-inducible factor 1 alpha inhibitor
0,241  0,084  Antineoplastic (renal cancer)
0,175  0,019  Dopamine D2 antagonist
0,239  0,087  5 Hydroxytryptamine 1E antagonist
0,190  0,041  CDC-like kinase 1 inhibitor
0,227  0,078  Cytostatic
0,273  0,126  Stroke treatment
0,161  0,014  Dopamine D3 antagonist
0,160  0,018  Acetylcholine nicotinic antagonist
0,187  0,046  Uterine stimulant
0,147  0,006  Alpha 2 adrenoreceptor agonist
0,182  0,050  Antiparkinsonian, tremor relieving
0,135  0,012  Dopamine uptake inhibitor
0,159  0,037  5 Hydroxytryptamine 2B antagonist
0,179  0,057  Cholinergic
0,134  0,012  ATPase (Vacuolar H+) inhibitor
0,149  0,033  Antiviral (Papilloma)
0,272  0,157  Antibacterial
0,171  0,058  Melanin inhibitor
0,139  0,028  Breast cancer-resistant protein inhibitor
0,127  0,017  Phosphodiesterase 11A inhibitor
0,127  0,017  Phosphodiesterase XI inhibitor
0,140  0,033  Sphingosine 1-phosphate receptor 2 agonist
0,150  0,043  Acetylcholine muscarinic antagonist
0,129  0,026  5 Hydroxytryptamine agonist
0,228  0,125  Antifungal
0,116  0,013  Alpha tubulin antagonist
0,164  0,063  Acetylcholine M1 receptor antagonist
0,164  0,063  Antiviral (Influenza A)
0,118  0,019  Nicotinic alpha4beta2 receptor antagonist
0,116  0,019  Neuronal nicotinic receptor antagonist
0,203  0,105  Acute neurologic disorders treatment
0,120  0,025  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,124  0,035  Alpha 1 adrenoreceptor antagonist
0,101  0,012  Nicotinic receptor alpha7 subunit antagonist
0,140  0,052  Alkylator
0,228  0,141  Antihypertensive
0,111  0,024  Alpha adrenoreceptor agonist
0,089  0,010  Nicotinic alpha3beta2 receptor antagonist
0,181  0,103  5 Hydroxytryptamine 3E antagonist
0,088  0,012  5 Hydroxytryptamine 2 agonist
0,200  0,125  Antineoplastic (sarcoma)
0,144  0,070  MAP3K9 inhibitor
0,104  0,035  Alpha 1a adrenoreceptor antagonist
0,226  0,157  Vasodilator, coronary
0,084  0,015  Dopamine transporter inhibitor
0,120  0,052  Activin receptor-like kinase 4 inhibitor
0,187  0,121  Antineoplastic (liver cancer)
0,182  0,116  NOS2 expression inhibitor
0,107  0,042  Carcinogenic, group 2A
0,095  0,030  Phosphodiesterase V inhibitor
0,148  0,087  Mutagenic
0,159  0,098  Antineoplastic (bone cancer)
0,159  0,098  LDLR expression enhancer
0,144  0,086  Chemopreventive
0,088  0,032  Calcium channel L-type blocker
0,159  0,104  Anesthetic general
0,070  0,015  5 Hydroxytryptamine 2C agonist
0,070  0,017  Alpha-mannosidase inhibitor
0,117  0,064  Microtubule formation inhibitor
0,126  0,073  Acetylcholinesterase inhibitor
0,123  0,070  Glutamate receptor antagonist
0,085  0,032  Antitreponemal
0,075  0,023  NMDA 2B receptor antagonist
0,148  0,096  Nitric oxide antagonist
0,056  0,004  Dopamine D1 agonist
0,185  0,134  Antipsychotic
0,081  0,030  Female sexual dysfunction treatment
0,082  0,033  5 Hydroxytryptamine uptake inhibitor
0,078  0,030  Beta tubulin antagonist
0,099  0,054  Phosphodiesterase 6D inhibitor
0,148  0,104  ATPase inhibitor
0,081  0,038  Phosphodiesterase 5A inhibitor
0,125  0,082  Antifungal enhancer
0,197  0,154  Antineoplastic (multiple myeloma)
0,096  0,055  SULT1E1 substrate
0,065  0,025  Ryanodine receptor antagonist
0,236  0,196  Antiparkinsonian
0,126  0,086  Psychosexual dysfunction treatment
0,133  0,095  Adenylate cyclase stimulant
0,166  0,128  Antineoplastic (lymphocytic leukemia)
0,210  0,173  GST M1-1 substrate
0,072  0,035  5 Hydroxytryptamine 2A agonist
0,057  0,021  Factor III inhibitor
0,049  0,015  Phenylethanolamine N methyltransferase inhibitor
0,092  0,058  Restless leg syndrome treatment
0,089  0,056  Calcium antagonist
0,164  0,130  Cyclic AMP phosphodiesterase inhibitor
0,157  0,125  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,053  0,022  Mannosidase inhibitor
0,086  0,055  mTOR complex 2 inhibitor
0,097  0,066  Antiemetic
0,048  0,018  Substance P antagonist
0,081  0,054  Xanthine oxidase substrate
0,091  0,066  Prolactin inhibitor
0,174  0,149  Radioprotector
0,080  0,057  Antineoplastic antibiotic
0,064  0,041  Adrenaline uptake inhibitor
0,058  0,035  5 Hydroxytryptamine 7 agonist
0,115  0,094  Papain-like protease (SARS coronavirus) inhibitor
0,157  0,137  Antiprotozoal (Leishmania)
0,044  0,025  Neurokinin 1 antagonist
0,050  0,032  Nicotinic receptor alpha4 subunit antagonist
0,064  0,047  5 Hydroxytryptamine 1B antagonist
0,168  0,153  Antiprotozoal (Trypanosoma)
0,061  0,047  Prolactin release inhibitor
0,050  0,038  5 Hydroxytryptamine 4 antagonist
0,177  0,167  UGT1A9 substrate
0,137  0,127  Antimigraine
0,021  0,012  Endothelin B receptor antagonist
0,027  0,020  Endothelin receptor antagonist
0,036  0,030  Vesicle monoamine transporter inhibitor
0,034  0,028  5 Hydroxytryptamine 3B antagonist
0,040  0,035  GABA B receptor antagonist
0,066  0,063  Acetylcholine M4 receptor antagonist
0,036  0,034  Dopamine D5 agonist
0,044  0,042  Phosphodiesterase 6C inhibitor
0,117  0,116  Antiviral (Herpes)
0,189  0,189  Vasodilator, peripheral

